Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
3
38%
Ph phase_4
3
38%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
Phase 43 (37.5%)
N/A3 (37.5%)

Trials by Status

completed8100%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8